| Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors S Shiina, R Tateishi, T Arano, K Uchino, K Enooku, H Nakagawa, ... Official journal of the American College of Gastroenterology| ACG 107 (4 …, 2012 | 796 | 2012 |
| Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma N Fujiwara, H Nakagawa, Y Kudo, R Tateishi, M Taguri, T Watadani, ... Journal of hepatology 63 (1), 131-140, 2015 | 634 | 2015 |
| ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development H Nakagawa, A Umemura, K Taniguchi, J Font-Burgada, D Dhar, H Ogata, ... Cancer cell 26 (3), 331-343, 2014 | 483 | 2014 |
| Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling G He, D Dhar, H Nakagawa, J Font-Burgada, H Ogata, Y Jiang, ... Cell 155 (2), 384-396, 2013 | 482 | 2013 |
| Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer J Font-Burgada, S Shalapour, S Ramaswamy, B Hsueh, D Rossell, ... Cell 162 (4), 766-779, 2015 | 465 | 2015 |
| p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells A Umemura, F He, K Taniguchi, H Nakagawa, S Yamachika, ... Cancer cell 29 (6), 935-948, 2016 | 418 | 2016 |
| Constitutive NF-κB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth K Sakamoto, S Maeda, Y Hikiba, H Nakagawa, Y Hayakawa, W Shibata, ... Clinical Cancer Research 15 (7), 2248-2258, 2009 | 299 | 2009 |
| Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation H Nakagawa, S Maeda, Y Hikiba, T Ohmae, W Shibata, A Yanai, ... Gastroenterology 135 (4), 1311-1321, 2008 | 279 | 2008 |
| Serum IL‐6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences H Nakagawa, S Maeda, H Yoshida, R Tateishi, R Masuzaki, T Ohki, ... International journal of cancer 125 (10), 2264-2269, 2009 | 200 | 2009 |
| Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition A Umemura, EJ Park, K Taniguchi, JH Lee, S Shalapour, MA Valasek, ... Cell metabolism 20 (1), 133-144, 2014 | 183 | 2014 |
| Liver cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling D Dhar, L Antonucci, H Nakagawa, JY Kim, E Glitzner, S Caruso, ... Cancer cell 33 (6), 1061-1077. e6, 2018 | 181 | 2018 |
| Cutting edge: the IκB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis W Shibata, S Maeda, Y Hikiba, A Yanai, T Ohmae, K Sakamoto, ... The Journal of Immunology 179 (5), 2681-2685, 2007 | 165 | 2007 |
| CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity N Fujiwara, H Nakagawa, K Enooku, Y Kudo, Y Hayata, T Nakatsuka, ... Gut 67 (8), 1493-1504, 2018 | 157 | 2018 |
| Inflammation-and stress-related signaling pathways in hepatocarcinogenesis H Nakagawa, S Maeda World J Gastroenterol 18 (31), 4071-4081, 2012 | 152 | 2012 |
| Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH T Ohki, R Tateishi, S Shiina, E Goto, T Sato, H Nakagawa, R Masuzaki, ... Gut 58 (6), 839-844, 2009 | 147 | 2009 |
| Lipid metabolic reprogramming in hepatocellular carcinoma H Nakagawa, Y Hayata, S Kawamura, T Yamada, N Fujiwara, K Koike Cancers 10 (11), 447, 2018 | 142 | 2018 |
| Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis H Nakagawa, Y Hikiba, Y Hirata, J Font-Burgada, K Sakamoto, ... Proceedings of the National Academy of Sciences 111 (3), 1090-1095, 2014 | 132 | 2014 |
| Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer Y Hayakawa, Y Hirata, H Nakagawa, K Sakamoto, Y Hikiba, H Kinoshita, ... Proceedings of the National Academy of Sciences 108 (2), 780-785, 2011 | 127 | 2011 |
| Autotaxin as a novel serum marker of liver fibrosis H Nakagawa, H Ikeda, K Nakamura, R Ohkawa, R Masuzaki, R Tateishi, ... Clinica chimica acta 412 (13-14), 1201-1206, 2011 | 112 | 2011 |
| Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK H Nakagawa, S Maeda Pathology research international 2012, 2012 | 111 | 2012 |
